Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2020
SIETES contiene 93096 citas

 
 
 1 a 20 de 55 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ham AC, van Dijk SC, Swart KMA, Enneman AW, van der Zwaluw NL, Brouwer-Brolsma EM, van Schoor NM, Zillikens MC, Lips P, de Groot LCPGM, Hofman A, Witkamp RF, Uitterlinden AG, Stricker BH, van der Velde N. Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis. Br J Clin Pharmacol 2017;83:2292-302. [Ref.ID 102082]
2.Enlace a cita original Cita con resumen
Noordam R, Aarts N, Leening MJ, Tiemeier H, Franco O, Hofman A, Stricker BH, Visser LE. Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study. Eur J Clin Pharmacol 2016;72:211-8. [Ref.ID 100100]
3.Tiene citas relacionadas Cita con resumen
Kavousi M, Leening MJG, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker B, Hofman A, Franco OH. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA 2014;311:1416-23. [Ref.ID 97396]
4. Cita con resumen
Teichert M, Visser LE, Uitterlinden AG, Hofman A, Buhre PJ, Straus S, De Smet PAGM, Stricker BHCH. Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment. Br J Clin Pharmacol 2011;72:798-805. [Ref.ID 91787]
5.Enlace a cita original Cita con resumen
Newson RS, Felix JF, Heeringa J, Hofman A, Witteman JCM, Tiemeier H. Association between serum cholesterol and noncardiovascular mortality in older age. American Geriatris Society 2011;59:1779-85. [Ref.ID 91593]
6. Cita con resumen
Becker ML, Visser LE, Newton-Cheh C, Hofman A, Uitterlinden AG, Witteman JCM, Stricker BHCH. A common N0S1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers. Br J Clin Pharmacol 2009;67:61-7. [Ref.ID 84982]
7. Cita con resumen
van der Hooft CS, Schoofs MWCJ, Ziere G, Hofman A, Pols HAP, Sturkenboom MCJM, Stricker BHCH. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 2008;66:276-82. [Ref.ID 83645]
8. Cita con resumen
Haag MDM, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM, Stricker BHC. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke. Arch Intern Med 2008;168:1219-24. [Ref.ID 83421]
9. Cita con resumen
Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumandari V, Moorhouse M, van Meurs JB, Hofman A, Pols HAP, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukast P, Uitterlinden AG, Spector TD. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008;371:1505-12. [Ref.ID 82800]
10.
Luijendijk HJ, Tiemeier H, Hofman A, Heeringa J, Stricker BHCH. Determinants of chronic benzodiazepine use in the elderly: a longitudinal study. Br J Clin Pharmacol 2008;65:593-9. [Ref.ID 82509]
11.
van den Akker EL, Koper JW, van Rossum EF, Dekker MJH, Russcher H, de Jong FH, Uitterlinden AG, Hofman A, Pols HA, Witteman JCM, Lamberts SWJ. Glucocorticoid receptor gene and risk of cardiovascular disease. Arch Intern Med 2008;168:33-9. [Ref.ID 81965]
12. Cita con resumen
Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, Niessen WJ, Breteler MMB, van der Lugt A. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-8. [Ref.ID 81401]
13. Cita con resumen
Teichert M, De Smet PAGM, Hofman A, Witteman JCM, Stricker BHCH. Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly. Drug Saf 2007;30:541-9. [Ref.ID 80362]
14. Cita con resumen
van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JCM, Kingma JH, Sturkenboom MCJM, Stricker BHCH. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 2006;166:1016-20. [Ref.ID 76948]
15.
Saracci R, Olsen J, Hofman A. Health research policy in the European Union. BMJ 2005;330:1459-60. [Ref.ID 74194]
16.
Shuit SCE, Oei HHS, Witteman JCM, van Kessel CHG, Nijhuis R L, van Leeuwen JPTM, de Jong FH, Zillikens MC, Hofman A, Pols H A P, Uitterlinden AG. Estrogen receptor alfa gene polymorphisms and risk of myocardial infarction. JAMA 2004;291:2969-77. [Ref.ID 70433]
17.Tiene citas relacionadas Cita con resumen
van Meurs JBJ, Dhonukshe-Rutten RAM, Fluijm SMF, van der Klift M, de Jonge R, Lindemans J, de Groot LCPGM, Hofman A, Witteman JCM, van Leeuwen JPTM, Breteler MMB, Lips P, Pols H A P, Uitterlinden AG. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41. [Ref.ID 70036]
18. Cita con resumen
Shoofs MWCJ, van der Klift M, Hofman A, De Laet CEDH, Herings RMC, Stijnen T, Pols H A P, Stricker BHCH. Thiazide diuretics and the risk of hip fracture. Ann Intern Med 2003;139:476-82. [Ref.ID 67432]
19.
van der Meer I M, de Maat MPM, Kiliaan AJ, van der Kuip DAM, Hofman A, Witteman JCM. The value of C-reactive protein in cardiovascular risk prediction. Arch Intern Med 2003;163:1323-8. [Ref.ID 66537]
20.
Van Leeuwen R, Vingerling JR, Hofman A, De Jong PTVM, Stricker BHCH. Cholesterol lowering drugs and risk age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ 2003;326:255-6. [Ref.ID 64952]
Seleccionar todas
 
 1 a 20 de 55 siguiente >>